Allergy Diagnostics Market - By Product & Service (Consumables, Instruments, Services), By Test Type (In Vivo, In Vitro), By Allergen (Inhaled Allergens, Food Allergens, Drug Allergens), By End-use (Diagnostic Laboratories), & Forecast, 2023 – 2032

Allergy Diagnostics Market Size

Allergy Diagnostics Market size was valued at USD 5.4 billion in 2022 and is projected to witness more than 10.8% CAGR from 2023 to 2032 owing to increasing prevalence and high economic burden of allergic diseases.
 

The benefits associated with allergic disease diagnosis such as reliability in disease screening and reduced severity of disease with a better diagnosis & management are forecasted to positively impact the industry progress. Risk factors comprising dietary influences or food allergens, inhaled allergens and drug allergens among others are contributing to the allergic reactions significantly.
 

Further, the economic burden of these food allergies cost around USD 25 billion each year in the U.S. The allergy diagnostic products are proved to be an ideal instrument to perform allergy evaluation. These diagnostic tests can be used to make decisions on the diagnosis and treatment of individuals with allergic diseases, including the prescription of drugs for relevant treatment therapies. Ongoing advancements have favored the evolution of these diagnostic tests that are associated with offering optimum specificity & sensitivity. This availability of unique and non-invasive diagnostic procedures are allowing ease and accuracy in early diagnosis and prevention of allergic disease. Reduced time minimized the risk of other infections during testing, and less pain & discomfort will further stimulate the adoption of the product.
 

Allergic disease includes number of conditions that are caused by the hypersensitivity of body's immune system to typically harmless substances present in the environment. This includes allergic rhinitis, asthma, different types of food and drug allergies, etc. Thus, the overall process to evaluate and determine the nature of an allergy to provide proper and early treatment to the patient can be considered as allergy diagnostics.
 

High cost of instruments used in allergy diagnostics and lack of awareness related to allergic diseases are some of the variables that are expected to hamper the market growth. Allergy diagnostic instruments including ELISA analysers, luminometers, and scanners among others are considerably costly attributable to integrated advance features that offer higher efficiency. Similarly, the fully automated ELISA analysers can cost up to USD 15,000. Hence, smaller diagnostic laboratories find it difficult to deploy such units thereby limiting the market expansion.
 

COVID-19 Impact

The recent outbreak of COVID-19 had a negative impact on the allergy diagnostics industry revenue in 2020. Various restrictions were imposed across several countries globally to avoid the spread of the virus. The COVID-19 outbreak had affected the overall healthcare industry. Numerous factors comprising halting of non-emergent medical services, demand and supply shortages, and other interruptions in diagnostic challenges impacted the market revenue.
 

Allergy Diagnostics Market Trends

Significant increase in number of patients suffering from allergic diseases attributable to growing environmental pollution levels, unhealthy habits such as smoking, and rise in occupational & seasonal allergy incidences among others will primarily drive the market trends. As per the Asthma and Allergy Foundation of America, allergic rhinitis, a type of respiratory allergy, is among the major health problems globally that causes itching, nasal obstruction, fatigue, and other complications. This can cause due to various seasonal or inflammatory disorders that needs proper diagnosis and treatment facilities.
 

Increasing prevalence of such ailments fuel the demand for allergy diagnostic devices significantly. This rising diseased population is resulting in high adoption of advanced allergy diagnostic devices that enable a doctor to examine the severe allergic conditions more effectively with highest precision.
 

Allergy Diagnostics Market Analysis

Based on product and service, the allergy diagnostics market is bifurcated into consumables, instruments, and services. The consumables segment is anticipated to account for major revenue share of over 55% in 2022 in the market. It is projected to maintain its dominance throughout the forecast period owing to rise in allergic disorders that in turn will demand for prompt diagnosis. Additionally, the availability of test kits to each allergen significantly aids the diagnosis mechanism of numerous allergy diseases.
 

Based on test type, the allergy diagnostics market is segmented into in vivo and in vitro tests. The in vivo tests segment was valued at around USD 2.9 billion in 2022. The benefits associated with the different types of in vivo tests including patch test, skin prick tests, challenge tests are the primary growth factors augmenting the segmental progression. In vivo tests are more reliable, cost-effective, convenient, and safe in comparison to in-vitro tests. For better reliability, in vivo tests include skin exams through standardized allergenic extracts. Further, these tests examine the susceptibility and reactivity of dermal mast cells, that can indicate allergic sensitivity.
 

Based on allergens, the allergy diagnostics market is categorized into drug allergens, inhaled allergens, food allergens, and other allergens. The food allergens segment is predicted to witness the fastest growth with a 11.3% CAGR over the forecast timeframe. This is primarily attributed to the rise in number of people suffering with food allergy reactions owing to food items such as peanuts, eggs, milk, soy, and fish among others.
 

Among them, milk allergy is the most common type, followed by egg and peanuts. Considerable surge in the U.S. children with food allergies have been recorded over the past two decades. Some of the common indications related to food allergy includes swelling of face and lips, itching in mouth, abdominal pain, etc.
 

Based on end-use, the allergy diagnostics market is segmented into hospital-based laboratories, diagnostic laboratories, and others. The diagnostic laboratories segment is slated to grow at more than 11.2% CAGR from 2022 to 2030. Rise in target population of people suffering from different allergy disorders, increasing prevalence of chronic respiratory diseases, surging environmental pollution levels and availability of significant number of independent diagnostic laboratories among others are prime factors responsible for growing patient footfall in diagnostic laboratories.
 

Additional, availability of well-trained healthcare personnel, better infrastructure and advanced equipment, and consistent rise in number of diagnostic laboratories in countries are anticipated to further fuel the segment forecasts. Moreover, rising preference rate of patients for precise diagnosis and faster result-oriented process adherence are other attributes supporting the segment size.
 

North America region held the leading revenue share in the global allergy diagnostics market and is expected to reach over USD 5.3 billion in 2032. Growing prevalence of allergic rhinitis along with increasing awareness levels for proper diagnostic procedures in the region is projected to spur the market revenue. The U.S. held the dominating position in the North America market in 2022 and is estimated to record healthy growth with a 10.1% CAGR during the analysis period. Favorable reimbursement scenario, rising funding for allergy diagnostic companies to come up with novel product launches, and surge in demand for rapid diagnostic test kits are among the key factors supporting the regional trend.
 

Further, there is a consistent rise in number of food and skin related allergy population in the country. For instance, according to the data published by Centers for Disease Control and Prevention, in 2021, approximately one-third of adults aged 18 and over had a eczema, seasonal or food allergy in the country. Moreover, food allergy was more prevalent in non-Hispanic black adults and women and adults between 18-44 age group. Allergies are the sixth leading cause of chronic illnesses in the country.
 

Allergy Diagnostics Market Share

Few of the leading players operating in the allergy diagnostics market include

• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Omega Diagnostics Group PLC
• Siemens Healthcare Diagnostics, Inc.
• Stallergenes SA 

The market is competitive in nature, with major companies, regional and local players, and start-ups consolidating the industry competition. The leading market players are involved in strategic developments including product launches, partnerships, mergers, and acquisition, and to further improve their market positioning and revenue generating capabilities.
 

Allergy Diagnostics Industry News:

• In August 2022, Reacta Healthcare, a UK-based company, secured its first U.S. patent for food allergy treatment or challenge meals used in oral food challenges (OFCs). The company already held patents across Europe, Hong Kong, Canada, Australia and UK. This development is expected to play a vital role in taking the U.S. business growth in the coming years.
   

Allergy diagnostics market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Product & Service, 2018 - 2032 (USD Million)

• Consumables
• Instruments
• Services

By Test Type, 2018 - 2032 (USD Million)

• In Vivo
  • Skin Prick Tests
  • Intradermal Skin Test
  • Others
• In Vitro

By Allergen, 2018 - 2032 (USD Million)

• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Other Allergens

By End-use, 2018 - 2032 (USD Million)

• Hospital-based Laboratories
• Diagnostic Laboratories
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Sweden
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
  • Peru
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Israel